(COLUMBUS, Ohio) -- Ohio Attorney General Mike DeWine announced today that Ohio has joined with other states and the federal government to settle allegations that Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) paid kickbacks and engaged in off-label marketing campaigns that improperly promoted four drugs: Atrovent, Combivent, Micardis and Aggrenox.
BIPI, a Connecticut based company, will pay the states and the federal government $95 million, of which $34,468,649.22 will go to the Medicaid programs to resolve civil allegations that the company unlawfully marketed Aggrenox, Combivent, Atrovent and Micardis and thereby caused false claims to be submitted to the government health care programs.